A Label-Free Approach for Cell-Level Drug Dosage Response Tests With an Optimized Flow Cytometry Device.

Area of Science:

• Biophysics
• Biotechnology
• Cancer Research

Background:

• Chemotherapy is vital for cancer treatment but traditional screening methods are complex and expensive.
• There is a need for efficient, high-throughput analytical methods for drug screening and response testing.

Purpose of the Study:

• To develop and optimize a novel biochip for profiling cancer cell biophysical properties.
• To assess the efficacy of the biochip in differentiating live and dead cancer cells and detecting drug responses.

Main Methods:

• Utilized a high-throughput seven-electrode double-differential biochip to analyze MCF-7 breast cancer cells.
• Optimized electrode dimensions (E:F:G = 2:5:1) and buffer conductivity (1.6 S/m) for precise cell status assessment.
• Monitored impedance signal characteristics (e.g., opacity, phase) to evaluate cellular responses to chemotherapy drugs.

Main Results:

• Achieved approximately 94.25% accuracy in differentiating live and dead MCF-7 cells.
• Identified distinct impedance signatures corresponding to varying chemotherapy drug concentrations.
• Demonstrated that changes in impedance signal characteristics reflect physiological shifts in cells under drug exposure.

Conclusions:

• The optimized biochip offers an efficient and novel methodology for drug dosage response testing.
• This approach enables precise and personalized cancer treatment strategies.
• The findings have the potential to improve patient outcomes and quality of life in cancer therapy.